Cite
HARVARD Citation
Dignass, A. et al. (n.d.). S730 Ozanimod Is an Efficacious Oral Therapy After 5-ASA Failure in Immunomodulator- and Biologic-Naive Patients With Ulcerative Colitis: Post Hoc Analysis From True North. American journal of gastroenterology. pp. e512-e513. [Online].